Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Doused in Denmark

David S. Pisetsky, MD, PhD  |  Issue: August 2009  |  August 1, 2009

As the EULAR conference wound down on Saturday, the clouds finally moved out to take up residence some place else in the Baltic. The sun shined brilliantly and the sky turned radiant blue. The conference ended with two summary lectures (kudos to the lecturers for reviewing thousands of abstracts to create such an interesting potpourri).

After a glass of wine with the last stalwarts in the lobby of the Bella Center, I went with friends to the Tivoli Gardens, a glorious amusement park that had its share of misery during World War II. While I sipped a Carlsberg in the warmth of the afternoon sun, members of the Tivoli Guard paraded by in snappy red and white uniforms, playing their fifes and drums as the Demon roller coaster roared through the park.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A meeting with the climatic vicissitudes of the 2009 EULAR congress can’t help but inspire metaphors to describe the state of our specialty. As I took the last sips of my beer, I asked myself, “What is the real rheumatology today?” Is it the Little Mermaid, solitary in a roiling sea pelted by cold rain from dense black clouds? Or, is it a Tivoli guard, a beaming youth giddy with pride as he marches triumphantly with a bearskin helmet?

The wildly contrasting scenes in Copenhagen presented too stark a choice for a metaphor for today’s rheumatology. It is time to go to the ACR meeting in Philadelphia to widen the selection. Who knows? Maybe rheumatology is really Rocky.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Pisetsky is physician editor of The Rheumatologist and professor of medicine and immunology at Duke University Medical Center in Durham, N.C.

Page: 1 2 3 | Single Page
Share: 

Filed under:EULAR/OtherMeeting ReportsOpinionRheuminationsSpeak Out Rheum Tagged with:DiseaseDisease-modifying antirheumatic drugs (DMARDs)EULARRheumatoid arthritisTravel

Related Articles

    EULAR Magic

    October 7, 2011

    Colorful characters and old friends meet in London

    Do RA Patients in Clinical Trials for Biologics Represent the Average?

    October 4, 2016

    It’s estimated that a majority of patients with rheumatoid arthritis (RA) have been exposed to biologic treatments. However, the randomized controlled trials demonstrating the safety and efficacy of these biologic agents have strict participant eligibility requirements. New research has examined the requirements of 30 trials for biologics and applied those standards to two large clinical cohorts. The result: A majority of these RA patients did not satisfy the criteria…

    Medical Renaissance

    February 12, 2011

    Europe has much that is new—including innovative research—emerging from its old-world settings

    March Madness on the High Seas: Hoops and Healthcare as Bedfellows

    June 1, 2010

    Hoops and healthcare as bedfellows

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences